First Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-618
Closed -$217K 133
2025
Q4
$217K Buy
+618
New +$209K 0.12% 122
2025
Q3
Sell
-618
Closed -$240K 132
2025
Q2
$240K Hold
618
0.14% 117
2025
Q1
$269K Hold
618
0.17% 105
2024
Q4
$228K Buy
618
+25
+4% +$10.5K 0.16% 112
2024
Q3
$308K Hold
593
0.21% 97
2024
Q2
$321K Hold
593
0.24% 91
2024
Q1
$307K Hold
593
0.23% 91
2023
Q4
$280K Hold
593
0.22% 95
2023
Q3
$258K Hold
593
0.23% 91
2023
Q2
$263K Hold
593
0.22% 92
2023
Q1
$273K Hold
593
0.23% 89
2022
Q4
$304K Hold
593
0.26% 77
2022
Q3
$270K Hold
593
0.24% 84
2022
Q2
$286K Hold
593
0.27% 83
2022
Q1
$292K Hold
593
0.27% 78
2021
Q4
$275K Buy
+593
New +$249K 0.24% 84

Other funds holding ELV

First Bancorp's ELV Position: Q1 2026 in Review

First Bancorp sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 618 shares — an estimated $217K sold.

First Bancorp first reported a position in ELV in Q4 2021 and held it in 16 quarters. The position peaked at $321K in Q2 2024. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • First Bancorp reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • First Bancorp sold 618 Elevance Health shares in Q1 2026, an estimated $217K.
  • First Bancorp first reported a position in Elevance Health in Q4 2021 and held it in 16 quarters.
  • First Bancorp's Elevance Health position peaked at $321K in Q2 2024.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on First Bancorp's 13F filing for Q1 2026, filed 20 Apr 2026.